CDK inhibitor CCT-251921, Purity ≥98%

Synonym: 1607837-31-9; CCT251921;CCT 251921; CDK inhibitor

Product Size

1 mg; 5 mg; 10 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

CCT-251921 is an CDK kinase inhibitor that disrupts cell division processes. It targets CDK19 and CDK8.

Molecular Weight

410.9

Molecular Formula

C₂₁H₂₃ClN₆O

Targets

CDK19: 2.6 nM; CDK8: 2.3 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Applications

CCT-251921 can be used to investigate its selective inhibition of CDKs and its potential effects on cancer cell proliferation.